Retained products of conception
Citation, DOI and article data
Retained products of conception (RPOC) refer to the persistence of placental and/or fetal tissue in the uterus following delivery, termination of pregnancy or a miscarriage.
RPOC complicate ~1-5% of all routine vaginal deliveries 12.
According to one prospective study, RPOC was present in after a third-trimester delivery in around 2.7% of women, whereas it was diagnosed in pregnancies ending during the second and first trimesters in 40% and 17%, respectively 12.
It occurs with greater frequency with:
Common symptoms include vaginal bleeding and abdominal or pelvic pain, similar to patients with gestational trophoblastic disease. Some patients may have fever 11.
Differentiation of these entities is important because retained products of conception are treated conservatively or with curettage, while gestational trophoblastic disease may require chemotherapy.
ß-human chorionic gonadotropin (beta-hCG) remains elevated in patients with gestational trophoblastic disease but falls to an undetectable level over 2-3 weeks, in cases of retained products.
Ultrasound is typically the first-line investigation in suspected retained products of conception:
- a variable amount of echogenic or heterogeneous material within the endometrial cavity
- in some instances, this may present like an endometrial or intrauterine mass
- presence of vascularity within the echogenic material supports the diagnosis but the absence of color Doppler flow has a low negative predictive value because retained products of conception may be avascular 9
- calcification may be present
Retained products of conception can be suspected on ultrasound if the endometrial thickness is >10 mm following dilatation and curettage or spontaneous abortion (80% sensitive).
MRI appearance is variable, and consists of soft tissue within the endometrial cavity, which may be variably enhancing. There may be variable degree of associated myometrial thinning and obliteration of the junctional zone.
Signal characteristics include 1:
- T1: variable heterogeneous signal
- T2: variable heterogeneous signal
- T1 C+ (Gd): variable enhancement
For ultrasound appearances consider:
- normal postpartum appearance
- blood clot within the endometrial cavity (often co-exists): non-vascular on color Doppler ultrasound
- gestational trophoblastic disease
- uterine arteriovenous malformation (if prominent blood flow is present)
- 1. Noonan JB, Coakley FV, Qayyum A et-al. MR imaging of retained products of conception. AJR Am J Roentgenol. 2003;181 (2): 435-9. AJR Am J Roentgenol (full text) - Pubmed citation
- 2. Nalaboff KM, Pellerito JS, Ben-levi E. Imaging the endometrium: disease and normal variants. Radiographics. 21 (6): 1409-24. Radiographics (full text) - Pubmed citation
- 3. Rumack CM, Wilson SR, Charboneau JW et-al. Diagnostic Ultrasound. Mosby. (2010) ISBN:0323053971. Read it at Google Books - Find it at Amazon
- 4. Leyendecker JR, Gorengaut V, Brown JJ. MR imaging of maternal diseases of the abdomen and pelvis during pregnancy and the immediate postpartum period. Radiographics. 24 (5): 1301-16. doi:10.1148/rg.245045036 - Pubmed citation
- 5. Kido A, Togashi K, Koyama T et-al. Retained products of conception masquerading as acquired arteriovenous malformation. J Comput Assist Tomogr. 27 (1): 88-92. J Comput Assist Tomogr (link) - Pubmed citation
- 6. Durfee SM, Frates MC, Luong A et-al. The sonographic and color Doppler features of retained products of conception. J Ultrasound Med. 2005;24 (9): 1181-6. J Ultrasound Med (full text) - Pubmed citation
- 7. Sadan O, Golan A, Girtler O et-al. Role of sonography in the diagnosis of retained products of conception. J Ultrasound Med. 2004;23 (3): 371-4. J Ultrasound Med (full text) - Pubmed citation
- 8. Abbasi S, Jamal A, Eslamian L et-al. Role of clinical and ultrasound findings in the diagnosis of retained products of conception. Ultrasound Obstet Gynecol. 2008;32 (5): 704-7. doi:10.1002/uog.5391 - Pubmed citation
- 9. Kamaya A, Petrovitch I, Chen B et-al. Retained products of conception: spectrum of color Doppler findings. J Ultrasound Med. 2009;28 (8): 1031-41. Pubmed citation
- 10 .Aseeja V. Management of retained products of conception with marked vascularity. Journal of the Turkish German Gynecological Association. 13 (3): 212-4. doi:10.5152/jtgga.2012.31 - Pubmed
- 11. Guarino A, Di Benedetto L, Assorgi C, Rocca A, Caserta D. Conservative and timely treatment in retained products of conception: a case report of placenta accreta ritention. International journal of clinical and experimental pathology. 8 (10): 13625-9. Pubmed
- 12. Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB, Kamaya A. Physiologic, histologic, and imaging features of retained products of conception. Radiographics : a review publication of the Radiological Society of North America, Inc. 33 (3): 781-96. doi:10.1148/rg.333125177 - Pubmed